Dossier assessment
Idecabtagene vicleucel (multiple myeloma, at least 3 prior therapies) – Benefit assessment according to §35a Social Code Book V
Project details
- Project no.
- A24-28
- Commission
- Commission awarded on 01.03.2024 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Withdrawn commission
- Department/Division
- Drug Assessment
- Topic
- Cancer
Connected Projects
-
Dossier assessment
Idecabtagene vicleucel (multiple myeloma) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V
Status: Commission completed
-
Dossier assessment
Idecabtagene vicleucel (multiple myeloma, at least 2 prior therapies) – Benefit assessment according to §35a Social Code Book V
Status: Commission completed